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Rett syndrome (RTT) is a debilitating neurological condition associated with mutations in the X-linked MECP2
gene, where apparently normal development is seen prior to the onset of cognitive and motor deterioration at
6–18monthsoflife.Atargeteddeletionofthemethyl-CpG-binding domain(MBD)codingregionanddisruption
of mRNA splicing was introduced in the mouse, resulting in a complete loss of Mecp2 transcripts and protein.
Postnatal comparison of XO and XY mutant Mecp2 allele-containing null mice revealed similar effects
on mouse growth and viability, suggesting that phenotypic manifestations are not modulated by
the Y-chromosome. Further assessment of Mecp2-null XY mice highlighted cerebellar and hippocampal/
amygdala-based learning deﬁcits in addition to reduced motor dexterity and decreased anxiety levels. Brain
tissues containing the hippocampal formation of XY Mecp2-null mice also displayed signiﬁcant changes in
genetic activity, which are related to the severity of the mutant phenotype.
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Introduction
Rett syndrome, RTT (MIM 312750), is a neurodevelopmental
disorder associated with onset of cognitive and motor
deterioration at 6–18 months of life (Hagberg et al., 1983).
Up to 80% of classical RTT patients harbour mutations in the
X-linked MECP2 gene encoding the methyl-CpG-binding
protein 2 (MeCP2) (Amir et al., 1999). MeCP2 binds
selectively to methylated CpG dinucleotides in mammalian
genomic DNA (Lewis et al., 1992) via a methyl-CpG-binding
domain (MBD) (Nan et al., 1993) and represses transcription
of target genes by transcriptional repression domain (TRD)
initiated interactions with histone deacetylases (HDAC1 and
HDAC2) and the transcriptional co-repressor SIN3A
(Nan et al., 1998). Mecp2 mRNA, in particular the 10 kb
isoform, is highly expressed in the mouse brain (Pelka
et al., 2005) and the protein is abundantly expressed in the
CNS of both human and mouse (LaSalle et al., 2001), with
most prominent expression being in the hippocampus, cere-
bellum and the cortex (Mullaney et al., 2004).
Initial attempts to produce Mecp2-null animals resulted in
embryonic lethality (Tate et al., 1996), leading to conditional
knockout approaches with Cre recombinase-mediated dele-
tion of exon 3 (Chen et al., 2001) or exon 3 and part of exon 4
(Guy et al., 2001) of the Mecp2 gene. The male mutant mice
develop an uncoordinated gait and a decline in spontaneous
movement commencing at 3–8 weeks of age and subsequently
exhibit body trembling, laboured breathing, hind-limb
clasping and signs of physical deterioration prior to death
at  10 weeks (Chen et al., 2001; Guy et al., 2001). Onset
of symptoms was variable in heterozygous mutant females
between 3 and 9 months, with 50% developing breathing
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 irregularities and hind-limb clasping motions and showing a
reduction in activity (Guy et al., 2001).
Mutant mice with a truncated MECP2 protein, similar to
that seen in RTT patients, were generated by introducing a
stop codon after the TRD (Shahbazian et al., 2002). These
mice, termed Mecp2
308, presented a milder phenotype. The
hemizygous males developed motor abnormalities and
tremors from 2 months of age, kyphosis at 4 months, EEG
abnormalities, reduced activity and stereotypic limb
movements. Ninety per cent of males survived to at least
1 year and maintained a normal body and brain weight,
whereas heterozygous females showed minimal symptoms
even at 1 year of age. The Mecp2
308 hemizygous males were
studied as a model of the female RTT condition, circumvent-
ing the difﬁculties caused by the early lethality of Mecp2-
null animals and allowed a detailed analysis of symptoms
without the confounding effect of X-inactivation (reviewed
by Warby, 2002).
Despite the emphasis on the assessment of male hemizy-
gous mice it still remains untested whether Y-linked gene
activity in the male may inﬂuence any downstream genetic
activity that will affect the manifestations of the null–mutant
phenotype. RTT is associated predominantly with females yet
when mutations of MECP2 arise in the male the phenotypes
cover a vast spectrum of neurodevelopmental disorders ran-
ging from congenital encephalopathy to differing degrees of
mental retardation depending on the nature of the mutation
(Moog et al., 2003). Furthermore, sex-related differences in
gene expression between normal adult male and female brains
have been predominantly encoded by Y-linked genes or have
been affected by X-inactivation (reviewed by Rinn and
Snyder, 2005). To determine whether the Y chromosome
has any impact on the phenotype, we have compared the
postnatal development of Mecp2-null 40 XY and 39 XO
mice. These mice have in common a maternally derived X-
chromosome that carries the mutant allele, and differ only by
the presence of an extra sex chromosome in the 40 XY.
Analysis of behavioural parameters of male Mecp2
308 mice
has revealed heightened levels of anxiety, aberrations in social
interactions, impaired nest building and altered diurnal activ-
ities, but otherwise normal conditioned fear and spatial learn-
ing (Shahbazian et al., 2002; Moretti et al., 2005).Presumably,
thelesserseverityofdisease featuresintheseanimals isaresult
of residual protein function. The early onset of disease fea-
tures and lethality of Mecp2-null mice has prevented detailed
analysis to ascertain the impact of complete loss of Mecp2 on
the behavioural phenotype. We, therefore, assessed Mecp2-
null male mice on a mixed 129/C57BL6 background, whereby
the extended mouse longevity allowed investigation of beha-
vioural deﬁcits associated with motor function, anxiety level
and learning capacity. Importantly, we show that in Mecp2-
null male mice, cerebellar learning and hippocampal-/
amygdala-based cognition are impaired, which has not
been reported in published accounts of the truncated protein
mutants (Shahbazian et al., 2002; Moretti et al., 2005).
We also show that increases in disease severity are accompa-
nied by a progressive increase in dysregulated expression of
a set of genes.
Materials and methods
Gene targeting and mouse crosses
The BAC clone B22804 (Reichwald et al., 2000) containing the entire
Mecp2 gene was digested with BamHI and a 10.8 kb fragment con-
taining exon 3, and the ﬁrst 3 kb of exon 4 was cloned into a pBC
(Stratagene) vector. An AcyI digest released an 800 bp fragment to
which the splice acceptor region from exon 3 and NotI and AcyI
restrictionsiteswereaddedtothe50 end.Thismodiﬁedfragmentwas
then cloned back into the construct. An HpaI and NotI digest sub-
sequently removed 2 kb of sequence containing exon 3 and the ﬁrst
 170 bp of exon 4 that code for the MBD. A loxP ﬂanked Pgk-neo
cassette was inserted into the HpaI/NotI ends of the targeting vector.
Electroporations were performed using 800 V, 3 mF and 200 ohms
(BioRad Gene Pulser), 1 · 10
7 R1 129 embryonic stem (ES) cells
(Nagy et al., 1993) and 80 mg construct DNA. Following selection
with G418, colonies were screened by polymerase chain reaction
(PCR) and integration conﬁrmed by Southern analysis (see Fig. 1
and Supplementary Figure 1). Correctly targeted ES cells were
injected into blastocysts, which were subsequently transferred into
Fig. 1 Targeting of the Mecp2 gene in ES cells. Targeting strategy resulting in removal of MBD coding regions. Initial ES cell clone
screening was performed with primers ﬂanking the neomycin cassette, resulting in a 2.1 kb PCR product compared with a 1.8 kb
wild-type product. Conﬁrmation of correct integration was performed with primer sets external to the arms of homology and in
the neomycin cassette giving 3.3 and 3.4 kb bands for primer sets spanning the 50 and 30 homologous arms, respectively. Southern
analysis on NotI/EcoRV-digested DNA using a probe complementary to sequence downstream of the 30 arm of homology showed
an 8.7 kb band in the correctly targeted clone owing to insertion of a NotI site, in contrast to a 20.3 kb wild-type band.
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 pseudo-pregnant females. Resulting chimeric males were bred with
129 females to generate heterozygous females, which were then
mated with 129 males. Heterozygous females from this line, termed
Mecp2
tm1neoTam were mated with Paf males on a C3H/HeSnJ back-
ground (LaneandDavisson,1990) andtheresulting129/C3H/HeSnJ
mixed background F1 offspring that contained 39 X
Mecp2 O and
40 X
Mecp2 Y genotypes was assessed. Heterozygous Mecp2
tm1neoTam
females were also bred with Tnap-Cre males of a 129 background
(Lomeli et al., 2000), resulting in Cre-mediated excision of the
Neomycin cassette. The resulting heterozygous females were then
mated with 129 males or C57BL6 males to generate the Mecp2
tm1Tam
line on a pure 129 or mixed 129/C57BL6 background, respectively.
Mouse phenotype analysis
Growth measurement
Mouse weights for mutant mice and wild-type littermates were
measured every 7 days commencing from postnatal day (P) 28.
Freewheel activity
Mouse activity was measured by placing freewheels in cages of
solitary conﬁned mice. Magnetic switches triggered with freewheel
use and custom-designed software recorded the number of revolu-
tionsin10sincrements.Upto12miceatatimeweremonitoredover
9 days, with the ﬁrst and last days excluded from analysis.
Elevated plus maze
The experimental animal was placed at the centre of a maze with a
plus sign conﬁguration, measuring 1.5 m across, which was raised 1
m above the ground. Two arms of the maze consisted of only a black
Perspex ﬂoor, whereas the other two were enclosed with black
Perspex. The amount of time spent in each type of arm and in
the centre region was recorded over a 5 min test period.
Rotating rod test (rotarod)
The rotarod apparatus consisted of a 3-cm-diameter rotating
cylinder with 24-cm-diameter end walls, where the speed of rotation
could be increased. A mouse was placed on the rotating cylinder,
which was set at the lowest speed, and the rotational speed was
increased every 15 s. The time taken for the mouse to fall off the
rod or be rotated twice along with the rod was recorded. Four
successive trials on the rod were performed for each mouse with
a 5 min interval between each trial.
Cued and contextual conditioning task
The stimulus unit of the economical exercise treadmill (model
EXER-04, Columbus Instruments, Columbus, Ohio, USA) consists
of stainless steel rods and was used to deliver a peak current of 1.6
mA. A cage was modiﬁed and the base removed, allowing the steel
rods to form the ﬂoor of the cage. The test procedure (Wehner et al.,
1997) was spread across two days. On Day 1 the mouse was placed in
the test chamber and allowed to explore the cage for 2 min, after
which a 30 s tone of white noise (static) was played, immediately
followed by an electrical shock lasting 2 s, delivered through the steel
coils. The tone and foot shock procedure was repeated 30 s later and
the mouse was then placed back into its home cage. Twenty-four
hours later the animal was placed back into the testing cage (context)
and was observed for 5 min, with this time broken down into 10 s
intervals, which were scored if the mouse froze in that interval. The
mouse was then returned to its home cage. One hour later the animal
was placed in a different test chamber. This chamber was larger and
contained bedding material and an almond scent was applied. The
number of freezing bouts was measured as before during a 3 min
period, broken into 10 s intervals, and then the auditory cue (static)
was played during a further 3 min and the number of freezing
episodes was noted.
Investigation of gene expression in
mutant mice
Quantitative real time reverse transcription–polymerase chain
reaction (QRT–PCR) analysis was performed on 10 mg brain tissue
samples from the region of the hippocampal formation that were
conservatively dissected from 11 to 12-week-old Mecp2
tm1Tam male
mice and wild-type littermates of a mixed 129/C57BL6 background.
RNAwasisolatedusingtheNucleospinRNAIIKit(MachereyNagel)
and quantiﬁed by spectrophotometry (Cary Bio300). cDNA was
generated from 500 ng RNA using the Advantage RT kit (BD
Biosciences) with oligo-dT primers. QRT–PCR was performed
using the Rotorgene 2000 thermal cycler (Corbett Research) with
SYBR green I (Molecular Probes) using heat-activated Taq polymer-
ase (Amplitaq Gold, PE Applied Biosystems). Reaction conditions
and primer sequences are shown in Supplementary Table 1. The
PCR products were run in a 2% gel to conﬁrm correct band size.
The levels of Gapdh and b-actin were used for the normalization of
sample results. All samples were measured in duplicate. Melt curve
analysis conﬁrmed presence of a single ampliﬁed product following
each run.
Statistical analysis
Means, standard deviations and standard errors of the mean (SEM)
were calculated using Microsoft Ofﬁce Excel 2003. Analysis of mouse
behavioural data was performed using KyPlot version 2.0 (http://
www.qualest.co.jp/Download/KyPlot/kyplot_e.htm), with one way
analysis of variance (ANOVA), Wilcoxon–Mann–Whitney rank
sum tests and unpaired t-tests being applied using a signiﬁcance
level of 0.05. QRT–PCR data tests of signiﬁcance (0.05) were
performed by a Wilcoxon–Mann–Whitney rank sum test (KyPlot).
Results
Generation of Mecp2-deﬁcient mice
Mecp2-deﬁcient mice were produced by replacing the coding
sequence for the MBD with a ﬂoxed Pgk-neo cassette. A non-
functional splicing site was introduced at the 50 end of the
gene sequence encoding the TRD, preventing splicing and
transcription of downstream Mecp2 sequence for the TRD,
theC-terminaldomainandthe30 UTR.Thecorrectly targeted
ES cells (Fig. 1 and Supplementary Figure 1) were used to
produce mutant mice by germline transmission.
Recombinase-mediated deletion of the ﬂoxed Pgk-neo (Sup-
plementary Figure 2) in the Mecp2
tm1neoTam mutant mice was
achieved by mating with Tnap-Cre mice (Lomeli et al., 2000)
to generate the Mecp2
tm1Tam mice. No detectable Mecp2
Effects of Mecp2 deﬁciency in mice Brain (2006), 129, 887–898 889
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 transcripts were found in hemizygous mutant male brain
tissue. Western analyses using mice with antibodies to both
the N- and C-terminal ends of MECP2 also revealed an
absence of detectable protein (Supplementary Figure 2).
Mecp2
tm1Tam mice are therefore completely null.
Y-chromosome function does not have any
signiﬁcant impact on the manifestation of
Mecp2-null phenotype
In our C3H/HeSn-Paf/J breeding stock (JAX no. 001529), the
loss of the Y chromosome, due to non-disjunction during
male meiosis (Lane and Davisson, 1990), results in an overall
62.1 : 38.9 ratio of females : males. Among the females, 12.1%
were 39 XO mice (Jamieson et al., 1998). Mecp2-null 39 XO
mice were produced by crossing Mecp2
tm1neoTam female mice
with Paf male mice. In total, 153 females (56%) and 121
(44%) males were produced, which is slightly less, but not
signiﬁcantly, than the expected ratio. In the Mecp2+/  ·
Paf/Y cross,  49% (59 out of 121) of all male pups were
mutant, which is consistent with the expected 50% of
males being mutant for Mecp2. About 6.2% (17 out of
274) of mice were Mecp2  39 XO R1 129 · C3H/HeSn,
which is consistent with the fact that half of the expected
12.1% of XO females will inherit the mutant allele from
the mother. Overall, 11% (17/153) of female mice were
Mecp2  39 XO. Since not all wild-type female mice were
successfully karyotyped to distinguish between 40 XX and
39 XO, it is not known if the Mecp2  39 XO has indeed
made up 50% of all the XO females as expected. Nevertheless,
the data suggest that there was no signiﬁcant loss of any
mutant mice before birth, irrespective of the genotype (i.e.
Mecp2 /Y, Mecp2+/  40 XX or Mecp2+/  39 XO).
BoththeMecp2 39XOandMecp2 40XYmicedisplayed
a high mortality rate during postnatal development. The age
by which 50% of the mice died was7weeks for the Mecp2 39
XO (n = 16) mice and 8 weeks for Mecp2  40 XY (n = 48)
(Fig. 2A). Only two male and one XO female survived to the
18th week. Mecp2  39 XO mutant females grew like wild-
type, heterozygote Mecp2+/  40 XX and wild-type females
(either 40 XX or 39 XO) during the ﬁrst 6–7 weeks. The
growth curve of Mecp2  39 XO mutants deﬂected down-
wards at 7–8th week owing to the onset of growth retardation
in some mice (Fig. 2B). The surviving XO mutants as a group
showed progressive loss of weight after 11 weeks (Fig. 2B).
Most XO mutant mice followed the trend of the population.
However, some showed growth arrest at as early as the 4–5th
week. Mecp2  40 XY males displayed a growth proﬁle similar
to that of the wild-type males, until the age of 5 weeks, after
which there was a progressive decline in weight gain (Fig. 2C).
Malocclusion was relatively common in both mutant males
and females, which could have underpinned the failure to
thrive due to feeding problems and malnourishment.
Death of the mice 39 XO and 40 XY mutants was preceded
by cessation of weight gain, then weight loss and onset of
lethargy. In summary, our data show that the mutant
40 XY and 39 XO mice exhibit similar proﬁles of postnatal
viability and growth (Fig. 2C), suggesting that Y-linked gene
activity has no signiﬁcant impact on the manifestation of
these two features of the Mecp2-null phenotype.
Mecp2
tm1Tam mice generated by removal of the neomycin
cassette were maintained on a 129 and a 129 · C57BL6
background after two backcrosses to C57BL6 mice. Mutant
males on the 129 background displayed an earlier onset of
postnatal lethality with half of the population succumbing by
5 weeks (Fig. 2D). Mutant males on the 129 · C57BL6 back-
ground showed a similar rate of lethality as the XY mutant of
129 · C3H/He background in the Paf crosses, with half of the
animals dying at the 8th week (Fig. 2D). The mutant mice
began to show failure to thrive from 5 weeks of age (Fig. 2E)
and attained a mean weight of only 15.2 6 1.3 g compared
with 21.0 6 0.7 g for wild-type littermates at 8 weeks (t-test
P = 0.009). No difference in growth and viability between
heterozygous and wild-type littermate females over the ﬁrst
13 weeks of life was observed (Fig. 2F). Mecp2
tm1Tam males
exhibited a marked decline in weight  1 week prior to death
and shed as much as 50% of their body weight. Prior to their
demise mutant mice displayed the typical features of other
Mecp2 mutants (Chen et al., 2001; Guy et al., 2001). They
showed an unusual gait with splaying hind limbs, clasping of
hind limb when suspended by the tail, dishevelled fur and
erected whiskers, laboured breathing, tremors and episodes
of seizures. The brains of mutant mice were signiﬁcantly
lighter (360 6 6 mg, n = 9) than those of wild-type
male littermates (450 6 8 mg, n = 8, t-test P = 3.19 · 10
 7).
The reduction in brain weight (by 30% for wild-type),
however, was not in proportion to that of the body weight,
at 50% reduction (12.8 6 1.4 g versus 23.2 6 0.6 g, t-test
P = 9.86 · 10
 6).
Mecp2
tm1Tam mice display reduced
locomotory activity and
cerebellar learning
To test if apraxia and ataxia exhibited by RTT patients
(reviewed by Jellinger, 2003) is related to loss of MECP2
function, we have investigated the motor abilities of the
Mecp2
tm1Tam XY mice. Mutant mice were selected while
they were still generally active and still gaining weight,
whereas those displaying seizures, laboured breathing or dis-
cernible tardiness were excluded from the analysis. The loco-
motory activities of mice were assessed by their activity on
freewheels, which recorded the number of revolutions over a
7dayperiod.Mutantmiceshowed signiﬁcantlylowerlevelsof
activity over the 7 days (t-test P = 1.04 · 10
 7), with a mean
daily revolution count of 1251 6 121, compared with 8711 6
335 of the wild-type littermates (Fig. 3A).
The rotarod test, consisting of a rotating rod that progres-
sively accelerates, measures motor coordination and balan-
cing ability (Crawley, 2000). Mutant males remained on the
rod for a much shorter mean time of 88 6 5 s, compared with
264 6 25 s for wild-type counterparts (Fig. 3B), representing
890 Brain (2006), 129, 887–898 G. J. Pelka et al.
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 a signiﬁcant difference in motor ability (t-test P = 0.0029).
To test the cerebellar learning ability (Crawley, 2000) the
performance over successive trials was monitored. Successive
trials on the rotarod for the Mecp2-null mice revealed
signiﬁcant deﬁcits in cerebellar learning, with mutant mice
failing to show signiﬁcant improvements in their ability to
stay on the rotarod (ANOVA P = 0.7135) compared with
wild-type littermates (ANOVA P = 0.0028).
Fig. 2 Survival and growth characteristics of Mecp2-deﬁcient mice. (A) Kaplan–Meier survival curves show that the age at which 50%
animals died for X
Mecp2 O female (n = 16) and X
Mecp2 Y male (n = 48) littermates was 7 and 8 weeks, respectively, and not signiﬁcantly
different (P = 0.38 Wilcoxon rank sum test). (B) Weight gain in X
Mecp2 O females is reduced compared with wild-type littermates. No
difference was observed between XX, XO and X
Mecp2 X females. (C) Weight gain in X
Mecp2 Y compared with XY animals and X
Mecp2 O
females. (D) Kaplan–Meier survival curves for pure 129 (n = 16) and 129/C57BL6 mixed background (n = 27) Mecp2
tm1Tam mutant males
show that 50% of mixed background males survived until 8 weeks compared with only 5 weeks when maintained on a pure background,
which represents a signiﬁcant difference in lifespan (P = 0.038). All wild-type males survived during this time course (n = 12) and are not
indicated. 129 animal deaths ranged from 2 to 8 weeks, whereas 129 · C57BL6 ranged from 4 to 18 weeks. (E) Weight gain for
129/C57BL6 mice revealed that mutant males (n = 11) exhibit poor weight gain compared with wild-type male littermates, (n = 10).
(F) Heterozygous females (n = 5), on the other hand, have comparable weight gains to wild-type females (n = 5). The dashed line indicates
no measurement taken at the 13th week. The sharp increase in weight indicated by asterisk (*) is the result of animal deaths.
Effects of Mecp2 deﬁciency in mice Brain (2006), 129, 887–898 891
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 Reduced levels of fear/anxiety in
Mecp2-null mice
TotestifMecp2deﬁciencyproducesalteredbehaviourtotheir
surroundings, we assessed the fear/anxiety of the mice on an
elevated plus maze (Crawley, 2000). Over a 5 min period the
total time spent in enclosed and open arms of the maze and in
the semi-sheltered centre region was recorded (Fig. 3C). The
natural tendency for wild-type mice is to prefer dark enclosed
spaces when anxious. Mutant animals spent more time (56 6
8 s) in the open arms and the centre region (68 6 10 s)
compared with 10 6 3 and 41 6 5 s, respectively, for the
wild-type mice. The signiﬁcant differences in the duration
spent in different areas of the maze (t-test, open
P = 0.00003, centre P = 0.0279) suggested that mutants
had apparently lower levels of anxiety. In addition, wild-
type mice very rarely explored the open arms and none
ventured to the ends of these arms, whereas mutant mice
generally explored all areas of the maze.
Mecp2-null mice show impaired fear
conditioning and contextual association
The cued and contextual conditioning task was undertaken to
test if Mecp2-null mice have any cognitive and learning
deﬁcits. Mice were trained to associate a foot shock with
an audible tone (cue) in a new environment (context).
Mice that previously experienced the combination of
shock, cue and context were assessed for their ‘freezing’
response to the testing environment and to associate and
relate the context and cue with prior foot shocks.As a control,
to measure baseline freezing, the mice were also placed in a
different environment (altered context). The results showed
that mutant mice were less capable in remembering the con-
text and associating this with the prior foot shocks (Fig. 3D).
Only 7 6 1.2 freezing episodes were recorded for the mutant
mice (n = 10) compared with 14.8 6 0.8 freezing events for
wild-type animals (n = 12, t-test P = 1.80 · 10
 6). The ability
of mutants to associate the auditory cue with shock was also
signiﬁcantly impaired—1.4 6 0.4 freezing episodes compared
with 5.75 6 0.25 (t-test P = 6.86 · 10
 9). Both groups showed
minimal freezing in the altered context with 1.25 6 0.25 for
wild-types and 1.2 6 0.25 for mutants (t-test P = 0.89).
Progressive dysregulation of gene
expression in Mecp2
tm1Tam mice
Genes were selected on the basis of preliminary microarray
analyses of whole brains of Mecp2
tm1Tam mice (data not
Fig. 3 Altered motor and cognitive abilities of Mecp2
tm1Tam mice. (A) Hemizygous males (M) are less active compared with controls (WT),
based on use of freewheels (X
Mecp2 Y, n = 13; XY, n = 12; t-test P < 0.001). (B) Mutant males displayed reduced motor dexterity on the
rotarod (t-test P = 0.0029) and improvement in performance was not signiﬁcant (ANOVA P = 0.7135) compared with the signiﬁcant
improvement in controls (ANOVA P = 0.0028), highlighting cerebellar learning deﬁcits in mutants (X
Mecp2 Y, n = 13; XY, n = 10).
(C) Increases in time spent in open arms of the elevated plus maze by mutant mice suggest that these mice have decreased levels of anxiety
(t-test, open P = 0.00003, centre P = 0.0279; n = 13, X
Mecp2 Y; n = 12, XY). (D) The cued and contextual learning task indicates mutant
mice have a reduced ability to associate a foot shock with their surroundings (context, t-test P = 1.80 · 10
 6) or with an auditory cue
(t-test P = 6.86 · 10
 9). When placed in an altered environment both mice did not show signiﬁcant differences in their number of
freezing episodes (t-test P = 0.89). X
Mecp2 Y, n = 10; XY, n = 12.
892 Brain (2006), 129, 887–898 G. J. Pelka et al.
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 shown) and the frontal cortex of human RTT brain (J. Gibson
and J. Christodoulou, unpublished results)and an association
with a RTT-like phenotype (Cdkl5) (Tao et al., 2004; Weaving
et al., 2004). The amygdala is believed to be involved in fear
conditioning (Fanselow and Kim, 1994), whereas the hippo-
campus, cingulate cortex, prefrontal cortex, perirhinal cortex
and sensory cortex are associated with contextual association
(Eichenbaum et al., 1996; Squire and Zola, 1996; Logue et al.,
1997), all areas of which show increased Mecp2 expression
(Pelka et al., 2005). Given the cognitive deﬁcits in
Mecp2
tm1Tam mice, we decided to focus the assessment of
gene expression to the hippocampal region of these mice.
QRT–PCR on hippocampal brain samples from six male
wild-typemice,sixmutantswithminimalphenotypicfeatures
(termed active mutants) and six mutants displaying signiﬁ-
cant disease features (sick mutants) were performed. Gapdh
and b-actin housekeeping genes were used to normalize sam-
ples, and all 18 brain samples were analysedin duplicate in the
same QRT–PCR run for each gene to minimize inter-run
variability. Following ampliﬁcation, melt curve analysis
conﬁrmed the presence of a single band (Fig. 4).
Ofthe 17non-X-linkedgenesanalysed,11werefound tobe
signiﬁcantly dysregulated between the sick mutant animals
and wild-type littermates, whereas 6 showed non-
signiﬁcant changes (Fig. 4A). The direction and magnitude
of signiﬁcant gene expression changes in active and sick
mutants is indicated in Fig. 5. Genes that showed signiﬁcantly
increased expression between sick mutants and their wild-
type littermates included Sgk, Sap30 and Pdk4. Sgk displayed
thegreatestfold-changeincrease,reachinglevels4.5timesthat
seen inwild-typeanimals, andan 2-foldincrease wasseenin
Sap30andPdk4expression.Signiﬁcantlydecreasedexpression
levels were observed for Fabp7, His2b, Nrarp, Gap43, Kif1b,
Lin7b and Zfp40, with fold-change reductions ranging from
1.5· for Zfp40 to 3.5· for Fabp7. No pattern of chromosomal
localization was identiﬁed, and Chromosomes 8 and 10 each
codedfortwoofthesegenes,whereasasinglegenewaslocated
from Chromosomes 2, 4, 6, 7, 13, 16 and 17. For the X-linked
genes, two had signiﬁcant changes (Fig. 4B) and their expres-
sion change for active and sick mutants is indicated in Fig. 5C
and I. Irak1 expression was increased 2.5-fold, whereas Xlr3a
was decreased 4.5-fold in sick mutants relative to wild-type
controls. Both of these genes reside on band A7.2, which
incidentally also contains Mecp2. Active and sick mutant
results were tested separately to reveal any differences in
genes expression that might be present between these groups.
No signiﬁcant changes were observed when active and wild-
types were compared with each other except for Sgk (Fig. 5A),
indicating that most changes are exacerbated in the more
severe disease state. The direction of change was consistent
for each gene, with a progressive increase between gene
dysregulation in active and sick mutant sample groups.
Fig. 4 Autosomal (A) and X-linked (B) genes assayed by QRT–PCR. A single gene speciﬁc product is produced for each gene
analysed. Chromosomal origins of genes are indicated, mt indicates a mitochondrial encoded gene and band positions are given in the
case of X-linked genes. A plus (+) signiﬁes that a signiﬁcant increase in transcript level was detected in sick mutants compared with
wild-type littermates, whereas a minus ( ) indicates a signiﬁcant reduction (data in Fig. 5). Genes for which non-signiﬁcant changes
were found are labelled ns. Signiﬁcance was assessed using the non-parametric Wilcoxon rank sum test.
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 Fig. 5 Genes assayed by QRT–PCR whose expression was signiﬁcantly affected in Mecp2
tm1Tam male mice. Genes found to be signiﬁcantly
increased included (A) serum glucocorticoid-regulated kinase, (B) Sin3-associated polypeptide 30 kDa, (C) the X-linked interleukin
1 receptor-associated kinase and (D) pyruvate dehydrogenase kinase 4. Signiﬁcantly downregulated genes included (E) fatty acid binding
protein 7, (F) H2B histone family member S, (G) notch-regulated ankyrin repeat protein, (H) growth-associated protein 43, (I) X-linked
lymphocyte-regulated 3a, (J) kinesin family member 1B, (K) lin 7 homolog b and (L) zinc ﬁnger protein 40. WT,
wild-type XY littermates; M active, Mecp2
tm1Tam XY mice with few disease features; M sick, Mecp2
tm1Tam XY mice with advanced
disease features. Each sample was measured in duplicate; n = 6 for each group type and inter-sample variability normalized using
Gapdh and Actin, with Mecp2 deﬁciency having no signiﬁcant impact on these housekeeping genes. Error bars indicate the SEM.
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 The increased magnitude of dysregulation observed in sick
mutants may be responsible for the progression of the disease
phenotype. It should be noted that animals used in the
assessment of motor and learning deﬁcits in our mutant
mice would be classiﬁed as active mutants, demonstrating
thatthelevelofgeneregulationdisruptionamongthismutant
subgroup if indeed responsible for the ‘sick’ mutant pheno-
type was sufﬁcient to cause behavioural deﬁcits. The level of
Cdkl5 expression was found to remain stable in both active
and sick mutants with means of 1.28 6 0.22 and 1.00 6 0.16,
respectively compared with 1.38 6 0.24 in the wild-type
group (P = 0.87; P= 0.34).This is consistent with the previous
ﬁnding that Cdkl5 and Mecp2 activity is regulated indepen-
dently (Weaving et al., 2004; Mari et al., 2005).
Discussion
Mecp2
tm1Tam mice display motor
deﬁciencies, altered levels of anxiety
and reduced cognitive function
Detailed behavioural analysis of the impact of Mecp2
deﬁciency has only previously been conducted on Mecp2
308
XY mice, which have a considerably milder phenotype
(Shahbazian et al., 2002; Moretti et al., 2005). Our
Mecp2
tm1Tam mice aged 8–11 weeks exhibited signiﬁcant
reductionsinactivityandmotorcoordinationwithsigniﬁcant
decreases in freewheel use and time spent on the rotarod,
respectively. This is in contrast to the 10-week-old Mecp2
308/Y
mice, which did not show any motor deﬁcits (Moretti et al.,
2005), at least not until 5 months of age, where a slight but
statistically signiﬁcant reduction in time spent on the rotarod
was observed (Shahbazian et al., 2002). Our data demon-
strate for the ﬁrst time that the complete absence of
Mecp2 leads to motor deﬁcits as early as 8–11 weeks.
Motor behaviour is dependant on many factors, with even
small irregularities in axonal signal transduction or neuro-
transmitter levels at synapses being able to be manifested as
motor impairments. Presumably, both granular and Purkinje
cells are responsible for the coordination deﬁcits observed in
Mecp2-deﬁcient animals, given that mice with deﬁcits in cer-
ebellar neuroanatomy such as hot-foot (defective innervation
of Purkinje cells) and staggerer (progressive loss of granule
and Purkinje cells) all perform poorly on the rotarod and fall
off between 0–100 s compared with the 300–400 s seen in
wild-types (Lalonde et al., 1996).
Our ﬁnding of reduced anxiety levels in 8- to 11-week-old
Mecp2
tm1Tam mutant males conducted using the elevated plus
maze contrastswith observationsontheMecp2
308mouse.Ata
similar age, Mecp2
308/Y mice displayed normal anxiety
responses (Moretti et al., 2005); however, when 8-month-
old Mecp2
308/Y mice were tested by the open ﬁeld test, a
reduced inclination to venture into the centre of the open
ﬁeld became apparent (Shahbazian et al., 2002), suggesting
increased levels of anxiety.
The cued and contextual conditioning task on the
Mecp2
tm1Tam mice revealed that there are cognitive deﬁcits
associated with memory and learning, highlighting for the
ﬁrst time that the complete absence of Mecp2 affects cognitive
processes. Conversely, published studies on Mecp2
308/Y
mutant mice did not show such a decrease, with normal
cognitive function in these animals being reported
(Shahbazian et al., 2002). Aside from our behavioural assess-
ment implicating Mecp2 deﬁciency with learning impair-
ments, recent work overexpressing human MECP2 in mice
at twice the level of the endogenous protein found enhanced
cerebellar motor learning at 10 weeks and hippocampal- and
amygdala-dependent learning at 20 weeks (Collins et al.,
2004). These animals, however, subsequently became hypoac-
tive and developed seizures and kyphosis at 30–52 weeks.
Repeated trials on the rotorod with our Mecp2
tm1Tam mice
revealed that they failed to improve signiﬁcantly, suggesting
further learning deﬁciencies in mastering this task. Both
C57BL6 and 129/SvJ mice have previously been shown to
be good learners and consequently perform well on the
cued and contextual task (Crawley, 2000). Both strains also
show improvement in successive trials on the rotarod
(Homanics et al., 1999), further highlighting the poor per-
formance of our Mecp2
tm1Tam animals. Our ﬁndings suggest
that in addition to hippocampaland amygdala-basedlearning
deﬁciencies, Mecp2
tm1Tam mice also exhibit deﬁcits in cerebral
function, not only in terms of motor ability but also in the
capacity to learn the task, and as a result they do not show
improved performance over successive trials on the rotarod.
Our ﬁndings showed a more severe impairment of mouse
ability compared with the Mecp2
308 mouse model for which
extensive behavioural studies have been conducted
(Shahbazian et al., 2002; Moretti et al., 2005). However,
cells of Mecp2
308 mice express a truncated protein with the
MBD and TRD elements of the protein still intact, suggesting
residual protein function, as thought to be the case in RTT
patients presenting with milder disease features. The disparity
in anxiety and cognitive responses between these two mouse
lines may be a consequence of having a truncated Mecp2
protein compared with no protein at all. The difference in
disease severity between the Mecp2
308 mouse and Mecp2-null
mice (this study and Chen et al., 2001; Guy et al., 2001) are
clearly evident and reﬂect the situation that among RTT
patients early truncating mutations or those affecting the
MBD may produce more severe disease features than muta-
tions at the 30 end of the gene (Weaving et al., 2003; Smeets
et al., 2005). Importantly, our study for the ﬁrst time demon-
strates that a speciﬁc behavioural response and thereby the
underlying mechanistic process may be differentially affected
between different introduced mutations.
Mecp2 deﬁciency and gene expression in
hippocampal tissue
A current focus of the research on RTT is centred on the
identiﬁcation of direct MECP2 targets and downstream
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 genes affected by Mecp2 mutation in an effort to elucidate the
pathophysiology of RTT. Putative target genes of MECP2
include the following: Hairy2a, a transcriptional repressor
protein responsible for silencing neuronal genes in non-
neuronal cells (Stancheva et al., 2003); Bdnf, believed to be
involved in the maintenance of neurons (Chen et al., 2003;
Martinowich et al., 2003) and the maternally imprinted gene
Dlx5, which is implicated in forebrain and craniofacial devel-
opment (Horike et al., 2005). The QRT–PCR assays under-
taken using our mice have identiﬁed a number of genes whose
expression is dysregulated and could potentially contribute to
the RTT phenotype. Not analysing whole-brain samples has
the advantage of avoiding brain regions where cells are poten-
tially less sensitive to a lack of MECP2, which could mask the
true extent of gene dysregulation in regions responsible for
eliciting RTT features. We focused our analysis on hippo-
campal tissue because of the association of learning/memory
memory process with this brain region and the impaired
performance of our mice in the cued and contextual condi-
tioning task. Functional aspects of genes found to be signiﬁ-
cantly dysregulated are shown in Supplementary Table 2
along with effects on mouse behaviour. We found that the
extent of dysregulation was progressive and increased in ani-
mals manifesting a more severe phenotype. The changes iden-
tiﬁed in gene expression may, however, be a consequence of
secondaryeffectsinducedbyMecp2deﬁciency,ratherthanthe
primary, direct interaction between Mecp2 and its target gene.
Having discounted the Y chromosome in modulating the
severity of phenotype in mice, it can be inferred that other
genes on the X-chromosome or genes on the autosomes are
likely to be inﬂuencing the RTT phenotype. Given the high
concentration of loci involved in cognition on the X-
chromosome (Zechner et al., 2001) we hypothesized a greater
level of X-linked gene dysregulation; however, only two genes,
Xlr3a and Irak1, were found to exhibit signiﬁcantly altered
levels of expression in our Mecp2-null mice. Recent micro-
array investigations comparing the expression patterns of X-
linked genes and parent of origin effects present in XO mice
revealed that Xlr3b, Xlr4b and Xlr4c are imprinted (Davies
et al., 2005; Raefski and O’Neill, 2005). The  3-fold increase
in levels of Xlr3b present in mice with a maternally derived X
have been attributed to cognitive deﬁcits associated with use
of a Y-maze-based reversal learning task, which involves the
pre- and orbital–frontal cortex and hippocampal regions
(Daviesetal.,2005)andparallelbehaviouraldeﬁcitsinTurner
syndrome patients with a maternal X. The Xlr3a gene was
found not to be imprinted (Davies et al., 2005). The impact of
the 4.5-fold decrease in Xlr3a levels in our Mecp2
tm1Tam mice
in terms of possible phenotype contribution is unknown, as
the role of Xlr3 genes in the context of cognition remains
enigmatic; they are, however, part of a larger family of
chromatin-associated proteins (Bergsagel et al., 1994). Simi-
larly, the impact of a 2.5-fold increase in Irak1 expression on
the brain remains unknown.
Two genes, Gap43 and Kif1b, were downregulated in the
hippocampus of the Mecp2
tm1Tam mice. Growth-associated
protein 43 (Gap43) is highly expressed during axonal growth,
but expression persists in the adult in highly plastic regions
and in pre-synaptic terminals (Benowitz et al., 1998; Udvadia
etal.,2001;Feig,2004).Theproteinisalsoupregulatedduring
long-termpotentiation,indicative ofaninvolvementinlearn-
ing and memory processes (Cammarota et al., 1997; Pascale
et al., 2004). Gap43-null mice displayed signiﬁcant impair-
ments in muscle strength, balance and limb coordination,
hyperactivity and reduced anxiety, with heterozygous mice
showing milder impairments (Metz and Schwab, 2004).
The performance deﬁcits in Gap43-deﬁcient mice are similar
to that observed in Mecp2
tm1Tam mice. The kinesin family
member 1B (Kif1b) gene is associated with axonal-based
transport, involved in supplying essential organelles and
materials to nerve endings using microtubules (Hirokawa,
1998). Disruption of the Kif1b gene leads to mice that develop
neurological disorders reminiscent of Charcot–Marie–Tooth
(CMT) disease (Zhao et al., 2001). The homozygous mice die
within 30 min of birth and exhibit respiratory distress, have
reduced brain size with a reduction in the number of neurons
and have abnormal synapses. Heterozygous mice displayed
progressively reduced motor capabilitiesassociated withmus-
cle weakness and motor dis-coordination with impaired per-
formance on the rotarod and balance beam test. Analysis of
the sciatic nerves of 2-month-old Kif1B+/  mice revealed a
reduction in synaptic vesicle proteins in nerve axons but not
in nerve cell bodies (Zhao et al., 2001). It is possible that
reduced levels of this motor protein, as a consequence of
Mecp2 deﬁciency, may not sustain the chemical or energy
requirements of neurons, leading to impairment of nerve
function and the features of RTT.
In summary, behavioural analysis of our Mecp2-null mice
revealed that Mecp2 deﬁcit not only impacts motor function
and affects anxiety levels but also cognitive function involving
the amygdala and hippocampus, which has not been shown
before. Our mouse model along with models of functionally
null mutations may provide a novel perspective on the impact
of Mecp2 deﬁciency on animal behaviour.
Supplementary material
Supplementary data are available at Brain Online.
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